Skip to main content

Windward Bio Group AG

WWB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002145089

In the last 90 days, Windward Bio Group AG insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in Windward Bio Group AG as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
0
0 vs. Q2 2026
Shares held
0
0 vs. Q2 2026
Total value
$0
$0 vs. Q2 2026
New holders
0
0 more added
Sold out
0
0 more reduced

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Windward Bio Group AG; share changes are against Q2 2026.

No institution reported holding WWB in Q3 2026.